FOSUN PHARMA (02196) announced that, in order to further broaden financing channels, certain of its controlling subsidiaries plan to initiate new financing lease arrangements with qualified leasing or financial leasing companies. The total financing amount will not exceed RMB 650 million. The arrangements include: (1) sale and leaseback transactions using certain owned asset equipment as the transfer subject and leased assets, and (2) direct leasing for newly purchased asset equipment.